EMEA-000149-PIP01-07-M02

Key facts

Invented name
Fluad and associated names
Active substance
Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/H1N1Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/H3N2Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain B
Therapeutic area
Vaccines
Decision number
P/208/2010
PIP number
EMEA-000149-PIP01-07-M02
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
Prevention of influenza
Route(s) of administration
Intramuscular use
Contact for public enquiries
Novartis Vaccines and Diagnostics S.r.l.
Tel. +39 0577 243046
E-mail: pip.seq@seqirus.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating